Surgery Partners SGRY
$26.78 +$0.09 (+0.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.78 0.00%
Open$26.64
Prev close$26.69
Day range$26.62 – $26.96
Volume1.11M
Market cap$3.50B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$815.30M-0.8% YoY
Operating profit$108.80M-19.5% YoY
Net profit$14.10M-44.3% YoY
Diluted EPS-$0.16+11.1% YoY
Free cash flow$79.00M+23.8% YoY
Operating cash flow$103.50M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin22.2%
Operating margin12.9%
Net margin-2.6%
Return on equity-5.1%
Return on assets-1.2%
Return on invested capital2.5%
Current ratio2.17
Liabilities / assets53.8%
Cash & investments$354.50M
Total debt$3.28B
Net cash (debt)-$2.93B
Free cash flow / sales6.0%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $815.30M | $848.90M | $810.90M | $3.31B | $885.00M |
| Total Operating Revenue | $815.30M | $848.90M | $810.90M | $3.31B | $885.00M |
| Cost of Revenue | $630.30M | $658.70M | $650.70M | $2.54B | $672.80M |
| Gross Profit | $185.00M | $190.20M | $160.20M | $765.00M | $212.20M |
| Operating Expense | $76.20M | $73.70M | $76.10M | $294.20M | $87.40M |
| Selling and Admin Expenses | $40.60M | $36.30M | $39.30M | $118.20M | $23.70M |
| -General & Admin Expense | $40.60M | $36.30M | $39.30M | $118.20M | $23.70M |
| Depreciation & Amortization & Depletion | $39.60M | $39.30M | $38.50M | $176.00M | $59.90M |
| -Depreciation & Amortization | $39.60M | $39.30M | $38.50M | $176.00M | $59.90M |
| Other Operating Expenses | -$4.00M | -$1.90M | -$1.70M | – | – |
| Operating Profit | $108.80M | $116.50M | $84.10M | $470.80M | $124.80M |
| Net Non-Operating Interest Income (Expense) | -$67.90M | -$69.80M | -$69.10M | -$272.60M | -$67.60M |
| Non-Operating Interest Expense | $67.90M | $69.80M | $69.10M | $272.60M | $67.60M |
| Other Income (Expense) | -$23.20M | -$14.40M | -$18.30M | -$81.30M | -$14.60M |
| Earnings from Equity Interest | $6.40M | $6.40M | $4.10M | $22.90M | $6.60M |
| Special Income (Charges) | -$29.60M | -$20.80M | -$22.40M | -$112.90M | -$29.90M |
| -Less:Restructuring and Mergern & Acquisition | $22.60M | $18.40M | $15.60M | $73.90M | $18.50M |
| -Less:Other Special Charges | $4.10M | – | $2.50M | $8.60M | $0.00 |
| -Gain on Sale Of Business | -$2.90M | -$2.40M | -$4.30M | -$30.40M | -$11.40M |
| Pretax Profit | $17.70M | $32.30M | -$3.30M | $116.90M | $42.60M |
| Tax | $3.60M | $2.60M | -$1.20M | $18.00M | $13.60M |
| Net Profit | $14.10M | $29.70M | -$2.10M | $98.90M | $29.00M |
| Profit from Continuing Operations | $14.10M | $29.70M | -$2.10M | $98.90M | $29.00M |
| Minority Interests | $35.20M | $44.70M | $33.80M | $176.80M | $44.00M |
| Net Income to Parent Company | -$21.10M | -$15.00M | -$35.90M | -$77.90M | -$15.00M |
| Net Income to Common Stockholders | -$21.10M | -$15.00M | -$35.90M | -$77.90M | -$15.00M |
| Basic EPS | -$0.16 | -$0.12 | -$0.28 | -$0.61 | -$0.12 |
| Diluted EPS | -$0.16 | -$0.12 | -$0.28 | -$0.61 | -$0.12 |
| Other Non-Operating Income (Expenses) | – | – | – | $8.70M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $7.05B | $8.05B | $8.04B | $8.12B | $8.12B |
| Total Current Assets | $1.08B | $1.13B | $1.08B | $1.15B | $1.15B |
| Cash and Cash Equivalents & Short-Term Investments | $354.50M | $216.70M | $182.30M | $239.90M | $239.90M |
| -Cash and Cash Equivalents | $354.50M | $216.70M | $182.30M | $239.90M | $239.90M |
| Receivables | $468.10M | $616.60M | $603.40M | $602.20M | $602.20M |
| -Accounts Receivable | $468.10M | $616.60M | $603.40M | $602.20M | $602.20M |
| Inventory | $77.50M | $98.80M | $100.50M | $96.60M | $96.60M |
| Other Current Assets | $179.90M | $145.60M | $196.30M | $212.00M | $212.00M |
| Total Non-Current Assets | $5.97B | $6.92B | $6.96B | $6.97B | $6.97B |
| Net PPE | $1.07B | $1.40B | $1.42B | $1.44B | $1.44B |
| -Gross PPE | $1.65B | $2.12B | $2.10B | $2.09B | $2.09B |
| -Accumulated Depreciation | -$579.70M | -$718.00M | -$686.00M | -$651.20M | -$651.20M |
| Investments and Advances | $225.40M | $226.90M | $225.40M | $234.00M | $234.00M |
| -Long Term Equity Investment | $225.40M | $226.90M | $225.40M | $234.00M | $234.00M |
| Goodwill and Other Intangible Assets | $4.64B | $5.24B | $5.25B | $5.24B | $5.24B |
| Other Non-Current Assets | $31.00M | $53.50M | $72.80M | $56.80M | $56.80M |
| Total Liabilities | $3.79B | $4.58B | $4.56B | $4.59B | $4.59B |
| Total Current Liabilities | $498.60M | $578.50M | $581.70M | $615.50M | $615.50M |
| Payables | $187.50M | $227.30M | $214.90M | $255.30M | $255.30M |
| -Accounts Payable | $140.70M | $175.20M | $168.60M | $208.70M | $208.70M |
| -Other Payable | $46.80M | $52.10M | $46.30M | $46.60M | $46.60M |
| Current Accrued Expenses | $221.50M | $207.70M | $217.00M | $213.50M | $213.50M |
| Short-Term Debt and Capital Lease Obligation | $89.60M | $143.50M | $142.60M | $142.00M | $142.00M |
| -Current Debt | $56.50M | $102.90M | $100.40M | $99.30M | $99.30M |
| -Current Capital Lease Obligation | $33.10M | $40.60M | $42.20M | $42.70M | $42.70M |
| Total Non-Current Liabilities | $3.29B | $4.00B | $3.98B | $3.98B | $3.98B |
| Long Term Debt and Capital Lease Obligation | $3.22B | $3.91B | $3.89B | $3.88B | $3.88B |
| -Long Term Debt | $3.00B | $3.65B | $3.61B | $3.60B | $3.60B |
| -Long Term Capital Lease Obligation | $224.40M | $266.30M | $271.90M | $279.90M | $279.90M |
| Non-Current Deferred Liabilities | $52.40M | $54.40M | $52.10M | $53.40M | $53.40M |
| Other Non-Current Liabilities | $19.00M | $33.80M | $41.60M | $41.20M | $41.20M |
| Total Equity | $3.26B | $3.47B | $3.48B | $3.53B | $3.53B |
| Stockholders' Equity | $1.66B | $1.67B | $1.69B | $1.71B | $1.71B |
| Capital Stock | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M |
| -Common Stock | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.55B | $2.54B | $2.55B | $2.54B | $2.54B |
| Retained Earnings | -$887.30M | -$866.10M | -$851.10M | -$815.20M | -$815.20M |
| Gains/Losses Not Affecting Retained Earnings | -$1.60M | -$8.90M | -$10.50M | -$13.80M | -$13.80M |
| Minority Interests | $1.59B | $1.80B | $1.79B | $1.81B | $1.81B |
| Prepaid Assets | – | $48.30M | – | – | – |
| Other Current Liabilities | – | – | $7.20M | $4.70M | $4.70M |
| -Goodwill | – | – | – | $5.19B | $5.19B |
| -Other Intangible Assets | – | – | – | $41.00M | $41.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $103.50M | $59.30M | $11.70M | $274.30M | $103.40M |
| Net cash flow from continuing operations | $103.50M | $59.30M | $11.70M | $274.30M | $103.40M |
| Net Income from Continuing Operations | $14.10M | $29.70M | -$2.10M | $98.90M | $29.00M |
| Gain/Loss from Continuing Operations | $6.60M | $1.20M | $6.90M | $30.90M | $9.60M |
| Depreciation & Depletion & Amortization | $39.60M | $39.30M | $38.50M | $176.00M | $59.90M |
| Deferred Tax | -$2.00M | $2.20M | -$1.30M | $16.70M | $13.40M |
| Other Non-Cash Items | $12.10M | $11.30M | $13.50M | $47.40M | $12.10M |
| Change in Working Capital | $27.10M | -$28.20M | -$49.60M | -$110.40M | -$18.40M |
| -Change in Receivables | $400,000.00 | -$15.00M | $3.60M | -$53.80M | -$46.10M |
| -Change In Other Working Capital | $26.70M | -$13.20M | -$53.20M | -$56.60M | $27.70M |
| Net cash flow from investing | $468.00M | -$19.80M | -$13.40M | -$246.60M | -$126.10M |
| Net Cash Flow from Continuing Investing Activities | $468.00M | -$19.80M | -$13.40M | -$246.60M | -$126.10M |
| Net PPE Purchase and Sale | $473.50M | -$21.50M | -$16.00M | -$32.20M | -$9.20M |
| Net Business Purchase and Sale | -$6.10M | $100,000.00 | -$3.30M | -$173.90M | -$121.30M |
| Net Other Investing Changes | $600,000.00 | $1.60M | $5.90M | -$40.50M | -$9.00M |
| Financing Cash Flow | -$433.70M | -$5.10M | -$55.90M | -$57.30M | $59.20M |
| Net Cash Flow from Continuing Financing Activities | -$433.70M | -$5.10M | -$55.90M | -$57.30M | $59.20M |
| Net Issuance Payments Of Debt | -$373.70M | $38.20M | $1.60M | $162.80M | $113.10M |
| Net Other Financing Charges | -$60.00M | -$43.30M | -$57.50M | -$220.10M | -$53.90M |
| Ending Cash Balance | $354.50M | $216.70M | $182.30M | $239.90M | $239.90M |
| Net Change in Cash | $137.80M | $34.40M | -$57.60M | -$29.60M | $36.50M |
| Beginning Cash Balance | $216.70M | $182.30M | $239.90M | $269.50M | $203.40M |
| Free Cash Flow | $79.00M | $37.50M | -$4.30M | $195.60M | $90.60M |
No comments yet — be the first to weigh in on SGRY.
Sign in to join the discussion.